drugset / Trial / NCT03450707
Thiamine as a Metabolic Resuscitator After Cardiac Arrest
Phase 2
Terminated
93 enrolled
Michael Donnino
National Heart, Lung, and Blood Institute (NHLBI) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a randomized, double-blind, placebo controlled study to investigate the effect of intravenous thiamine (vitamin B1) on lactate, cellular oxygen consumption, global oxygen consumption and biomarkers of neurologic injury after out-of-hospital cardiac arrest (OHCA). .
Timeline
- Start
- 2018-05-06
- Primary completion
- 2022-02-19
- Completion
- 2022-02-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Thiamine | Other / unclassified | 500 mg | Intravenous |